Breaking News, Financial News

Financial Report: Thermo Fisher Scientific

Life Sciences Solutions Segment revenue up 10% in the quarter

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific 1Q Revenues: $6.2 billion (+2%) 1Q Earnings: $788 million (-3%) Comments: Life Sciences Solutions Segment revenue grew 10% to $1.8 billion. Analytical Instruments Segment revenue was $1.1 billion in the first quarter, down from $1.3 billion in 1Q19. Specialty Diagnostics Segment revenue was flat at $0.96 billion in the first quarter, reflecting the divestiture of the Anatomical Pathology business in June 2019. Laboratory Products and Services Segment revenue ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters